Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Are eyes more than just windows to the soul? Exploring the link between age-related macular degeneration and Alzheimer's disease.
EF 2018-19
Résumé
Age-related macular degeneration (AMD) and Alzheimer’s disease are both degenerative conditions primarily affecting the elderly population. One type of AMD, “wet” AMD, is characterized by an increased number of leaky blood vessels within the retina, similar to what has been reported in the brains of Alzheimer’s animal models and patients.
We propose that these two diseases may have similar underlying pathologies via the development of leaky vessels that result in the disruption of the tight barriers protecting the eye/brain. We will further investigate this possible link by using the Tg2576 mouse model and human retinal cell cultures to determine whether leaky vessels and inflammation link these two conditions.
The purpose of these experiments is to understand the cause and progression of both conditions and whether the detection of AMD can lead to an early prognosis of Alzheimer’s disease. There are currently no cures or even treatments to slow down the progression of Alzheimer’s disease. Alzheimer’s disease medications have one of the highest failure rates in clinical trials: 99.6% of drugs tested between 2000-2015 failed. It is believed that the primary reason so many drugs fail is because the medication needs to be administered before cognitive symptoms arise. If a link is discovered between AMD and Alzheimer’s disease, this can lead to a new, painless and non-invasive way of diagnosing or detecting early signs of Alzheimer’s by simply examining the eyes. Furthermore, it may be possible to test current AMD medications, that are already FDA-approved, as potential therapeutics for delaying the progression or preventing Alzheimer’s disease. Ultimately, through our research we plan to demonstrate that the eyes are more than just windows to the soul.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406397
Name
Baeva Maria-Elizabeth
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Are eyes more than just windows to the soul? Exploring the link between age-related macular degeneration and Alzheimer's disease.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Age-Related Macular Degeneration; Alzheimer'S Disease; Angiogenesis; Eye Test; Hypervascularization; Immunology; Inflammation; Pathology; Retina; Therapeutics
Abstract
Age-related macular degeneration (AMD) and Alzheimer’s disease are both degenerative conditions primarily affecting the elderly population. One type of AMD, “wet” AMD, is characterized by an increased number of leaky blood vessels within the retina, similar to what has been reported in the brains of Alzheimer’s animal models and patients.
We propose that these two diseases may have similar underlying pathologies via the development of leaky vessels that result in the disruption of the tight barriers protecting the eye/brain. We will further investigate this possible link by using the Tg2576 mouse model and human retinal cell cultures to determine whether leaky vessels and inflammation link these two conditions.
The purpose of these experiments is to understand the cause and progression of both conditions and whether the detection of AMD can lead to an early prognosis of Alzheimer’s disease. There are currently no cures or even treatments to slow down the progression of Alzheimer’s disease. Alzheimer’s disease medications have one of the highest failure rates in clinical trials: 99.6% of drugs tested between 2000-2015 failed. It is believed that the primary reason so many drugs fail is because the medication needs to be administered before cognitive symptoms arise. If a link is discovered between AMD and Alzheimer’s disease, this can lead to a new, painless and non-invasive way of diagnosing or detecting early signs of Alzheimer’s by simply examining the eyes. Furthermore, it may be possible to test current AMD medications, that are already FDA-approved, as potential therapeutics for delaying the progression or preventing Alzheimer’s disease. Ultimately, through our research we plan to demonstrate that the eyes are more than just windows to the soul.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Baeva, Maria-Elizabeth
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~